<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240203060885N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-02-20</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effectiveness of psychological education of the patient and spouse in people with obstructive sleep apnea following the CPAP device, improving sleep quality and reducing daily sleepiness</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effectiveness of psychological education of the patient and spouse in people with obstructive sleep apnea following the CPAP device, improving sleep quality and reducing daily sleepiness</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-02-13</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>32</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/75299</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: In this study, permutation blocks method was used to generate the sequence of random assignment of people to the studied groups. Random allocation sequence of people was done using Random Allocation Software and block size of four. The permutation block method is one of the random allocation methods in which each block is selected according to the number of studied groups.
In this study, there are six blocks AABB (1), ABAB (2), ABBA (3), BBAA (4), BABA (5) and BAAB (6). One of the blocks is randomly selected. If the first block, AABB, is selected, the first and second people are assigned to group A, and the third and fourth people are assigned to group B, and this process continues until all the samples are assigned. The characteristic of this method is that the two study groups will have equal numbers, Blinding description: The participants in this research do not know about the sampling method and the members of the control group and only receive the intervention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Patients with obstructive sleep apnea.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: This group includes 17 patients with their partner, the affected patient has used the CPAP machine for one month, and after one month, intervention sessions (5 sessions) will be held for each person in person or online.The content of the sessions will be based on the cognitive-behavioral approach. In this way, one session of psychoeducation, two sessions of working on false beliefs of the patient and partner about apnea and the use of (cognitive) device, and two sessions will be behavioral.After finishing the sessions, the patient will use the device again for one month to determine the effectiveness of the intervention sessions. Intervention 2: Intervention group: This group includes 17 patients without a partner, the affected patient has used the CPAP machine for one month, and after one month, intervention sessions (5 sessions) will be held for the patient in person or online. The content of the sessions will be based on the cognitive-behavioral approach.In this way, one session of psychoeducation, two sessions of working on the patient's false beliefs about apnea and the use of the (cognitive) device, and two sessions will be behavioral. After finishing the sessions, the patient will use the device again for one month to determine the effectiveness of the intervention sessions. Intervention 3: Control group: The control group includes 17 patients along with their partner, the affected patient used the CPAP machine for one month, and after one month, all the content related to the intervention sessions was given to the patient and partner in the form of brochures without conducting the sessions. to be read weekly. After five weeks, the patient will use the device again for one month to determine the effectiveness of the intervention sessions.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahdiye Faramarzi Moghaddam</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hedayat St., 2.1 Hedayat, No. 83, second floor</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9194873999</zip>
        <telephone>+98 991 073 6552</telephone>
        <email>Faramarzimahdiye01@gmail.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mahdiye Faramarzi Moghaddam</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hedayat St., 2.1 Hedayat, No. 83, second floor</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9194873999</zip>
        <telephone>+98 991 073 6552</telephone>
        <email>faramarzimahdiye01@gmail.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with obstructive sleep apnea
patients who want to use CPAP device
completing questionnaires related to sleep quality and daily sleepiness
marriage</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>suffering from severe mental illnesses (psychotic, bipolar)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G47.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Sleep apnea</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: This group includes 17 patients with their partner, the affected patient has used the CPAP machine for one month, and after one month, intervention sessions (5 sessions) will be held for each person in person or online.The content of the sessions will be based on the cognitive-behavioral approach. In this way, one session of psychoeducation, two sessions of working on false beliefs of the patient and partner about apnea and the use of (cognitive) device, and two sessions will be behavioral.After finishing the sessions, the patient will use the device again for one month to determine the effectiveness of the intervention sessions.</i_keyword>
      <i_keyword>Intervention group: This group includes 17 patients without a partner, the affected patient has used the CPAP machine for one month, and after one month, intervention sessions (5 sessions) will be held for the patient in person or online. The content of the sessions will be based on the cognitive-behavioral approach.In this way, one session of psychoeducation, two sessions of working on the patient's false beliefs about apnea and the use of the (cognitive) device, and two sessions will be behavioral. After finishing the sessions, the patient will use the device again for one month to determine the effectiveness of the intervention sessions.</i_keyword>
      <i_keyword>Control group: The control group includes 17 patients along with their partner, the affected patient used the CPAP machine for one month, and after one month, all the content related to the intervention sessions was given to the patient and partner in the form of brochures without conducting the sessions. to be read weekly. After five weeks, the patient will use the device again for one month to determine the effectiveness of the intervention sessions.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Patients with obstructive sleep apnea who use a CPAP machine. Timepoint: The measurement is done before the start of the intervention, immediately after the end of the intervention and eight weeks after the intervention. Method of measurement: Using the Petersburg Sleep Quality Questionnaire and Epworth Daily Sleepiness Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Improving sleep quality. Timepoint: The measurement is done before the start of the intervention, immediately after the end of the intervention and eight weeks after the intervention. Method of measurement: Using the Petersburg Sleep Quality Questionnaire and the Epworth Daily Sleepiness Questionnaire.</sec_outcome>
      <sec_outcome>Reducing daily sleepiness. Timepoint: The measurement is done before the start of the intervention, immediately after the end of the intervention and eight weeks after the intervention. Method of measurement: Using the Petersburg Sleep Quality Questionnaire and the Epworth Daily Sleepiness Questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-02-04</approval_date>
        <contact_name>Ethics Committee of Mashhad University of Medical Sciences</contact_name>
        <contact_address>East Hedayat St., Hedayat 2.1, plauqe. 83, second floor Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
